CD5 and synovial sarcoma: Moreover, preliminary results from our group indicates that CD5 polymorphism also influences the clinical expression of primary SS [48] Considering the herein presented results and the previous findings in RA and SS [45], [48], the CD5 gene could be considered as a new shared genetic risk or disease-modifier factor in autoimmunity.